Latest Accounting News

Solis Minerals has expanded its lithium footprint with a fresh acquisition in Brazil, setting the stage for a busy drilling calendar across lithium and copper assets in South America.

Algorae Pharmaceuticals strengthened its balance sheet with $5.47 million cash reserves and broadened its commercial footprint through new licensing deals and AI-driven drug validation.

Livium Ltd boosted battery recycling revenue and secured a new centralised hub to expand capacity, while advancing rare earth and solar panel recycling technologies. Strategic funding for its lithium cathode plant remains under review.

49 Metals Limited (ASX:49M) raised $10 million in its IPO and began reverse circulation drilling at its Nevada Gold Mountain project, marking its debut quarter as a listed entity.

Top End Energy is progressing farm-out talks in the Beetaloo Basin amid growing industry validation, while its Kansas hydrogen project attracts new partners and it broadens into US AI data centre energy solutions.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Chalice Mining has bolstered its leadership and financing strategy while advancing a Feasibility Study for its Gonneville palladium-nickel-copper project, amid improving market conditions and promising exploration results.

MPR Australia has no ongoing operations following its $19 million asset sale and is weighing shareholder returns against new business acquisitions amid legacy claims.

Focus Minerals Ltd maintained steady gold production and processing efficiency at Coolgardie during the March 2026 quarter, generating robust sales revenue and a healthy cash position.

West Cobar Metals reports promising heap leach testwork at Salazar with strong rare earth recoveries, a significant expansion of its Bulla Park copper-antimony tenure, and confirmed widespread gold mineralisation at Mystique.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.